Synthetic DNA Vaccines: Improved Vaccine Potency by Electroporation and Co-Delivered Genetic Adjuvants

In recent years, DNA vaccines have undergone a number of technological advancements that have incited renewed interest and heightened promise in the field. Two such improvements are the use of genetically engineered cytokine adjuvants and plasmid delivery via in vivo electroporation (EP), the latter...

Descripción completa

Detalles Bibliográficos
Autores principales: Flingai, Seleeke, Czerwonko, Matias, Goodman, Jonathan, Kudchodkar, Sagar B., Muthumani, Kar, Weiner, David B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2013
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816528/
https://www.ncbi.nlm.nih.gov/pubmed/24204366
http://dx.doi.org/10.3389/fimmu.2013.00354

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3816528/
https://www.ncbi.nlm.nih.gov/pubmed/24204366
http://dx.doi.org/10.3389/fimmu.2013.00354

Ejemplares similares